Insider Selling: Phreesia, Inc. (NYSE:PHR) General Counsel Sells 3,496 Shares of Stock

Phreesia, Inc. (NYSE:PHR) General Counsel Allison C. Hoffman sold 3,496 shares of Phreesia stock in a transaction that occurred on Tuesday, February 18th. The shares were sold at an average price of $29.72, for a total value of $103,901.12. Following the sale, the general counsel now directly owns 142,630 shares in the company, valued at approximately $4,238,963.60. The trade was a 2.39 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink.

Phreesia Stock Down 0.9 %

Shares of PHR stock opened at $28.20 on Friday. The company has a debt-to-equity ratio of 0.04, a current ratio of 1.74 and a quick ratio of 1.74. Phreesia, Inc. has a one year low of $17.07 and a one year high of $30.53. The company’s fifty day moving average price is $27.29 and its 200-day moving average price is $23.84. The company has a market capitalization of $1.64 billion, a price-to-earnings ratio of -19.18 and a beta of 0.96.

Phreesia (NYSE:PHR) last issued its quarterly earnings results on Monday, December 9th. The company reported ($0.25) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.29) by $0.04. Phreesia had a negative return on equity of 32.78% and a negative net margin of 20.43%. The business had revenue of $106.80 million during the quarter, compared to analyst estimates of $106.33 million. During the same quarter in the prior year, the business posted ($0.58) EPS. Phreesia’s revenue for the quarter was up 16.6% compared to the same quarter last year. Sell-side analysts expect that Phreesia, Inc. will post -1.1 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in PHR. Vanguard Group Inc. grew its holdings in Phreesia by 1.3% during the 4th quarter. Vanguard Group Inc. now owns 4,823,110 shares of the company’s stock valued at $121,349,000 after buying an additional 61,048 shares in the last quarter. Greenhouse Funds LLLP boosted its position in shares of Phreesia by 27.9% during the fourth quarter. Greenhouse Funds LLLP now owns 2,873,892 shares of the company’s stock worth $72,307,000 after acquiring an additional 626,579 shares during the last quarter. Champlain Investment Partners LLC grew its stake in Phreesia by 4.1% during the third quarter. Champlain Investment Partners LLC now owns 2,503,837 shares of the company’s stock valued at $57,062,000 after acquiring an additional 97,847 shares in the last quarter. Franklin Resources Inc. increased its holdings in Phreesia by 0.8% in the 4th quarter. Franklin Resources Inc. now owns 1,509,617 shares of the company’s stock valued at $37,982,000 after acquiring an additional 11,986 shares during the last quarter. Finally, State Street Corp lifted its stake in Phreesia by 7.1% in the 3rd quarter. State Street Corp now owns 1,327,586 shares of the company’s stock worth $30,256,000 after purchasing an additional 88,517 shares in the last quarter. 92.10% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of analysts have recently commented on the stock. Needham & Company LLC restated a “buy” rating and set a $29.00 target price on shares of Phreesia in a report on Friday, January 10th. Piper Sandler reiterated an “overweight” rating and set a $33.00 target price (up from $31.00) on shares of Phreesia in a research note on Wednesday, January 29th. KeyCorp raised their price target on shares of Phreesia from $28.00 to $30.00 and gave the company an “overweight” rating in a report on Wednesday, January 8th. Robert W. Baird cut their price objective on Phreesia from $34.00 to $30.00 and set an “outperform” rating for the company in a report on Wednesday, December 11th. Finally, JMP Securities reaffirmed a “market outperform” rating and set a $30.00 target price on shares of Phreesia in a report on Tuesday, December 10th. Thirteen equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat, the stock currently has a consensus rating of “Buy” and an average target price of $31.15.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.